News
Enzalutamide plus ADT was associated with significant improvements in rPFS and time to castration resistance compared with darolutamide plus ADT.
The 500 mg regimen of abiraterone acetate demonstrated comparable anti-tumor activity and a favorable safety profile compared with the standard 1000 mg dose.
"We are not offering patients comprehensive management unless we consider hormone therapies," says Ashley G. Winter, MD. On July 17, 2025, a panel of experts convened by the FDA outlined the growing ...
An expert summarizes that TARA-002, a novel immunotherapy derived from Streptococcus pyogenes, is showing promising results in a phase 2 trial for non–muscle-invasive bladder cancer—particularly in ...
Data from the phase 3b study were recently published in Reviews in Urology, showing that administration of mitomycin intravesical solution in the home setting was feasible, safe, and effective.
Bladder cancer is a challenging and recurrent disease that significantly impacts both those experiencing it and those providing care. Its management demands ongoing surveillance and frequent ...
Metastasis-directed radiotherapy without systemic therapy (MRWS) demonstrated promising efficacy with manageable safety in patients with oligometastatic clear cell renal cell carcinoma (ccRCC), ...
She also emphasizes the role of bowel health, stating that constipation—common in malnourished individuals—can increase pressure on the bladder and hinder normal voiding. Fluid intake patterns in ...
The expanded labeling would enable the use of flibanserin to treat hypoactive sexual desire disorder in postmenopausal women.
Data showed that fracture risk rises briefly after menopausal hormone therapy discontinuation, then falls below never-users.
The WATER IV PCa trial is comparing first-line Aquablation therapy with radical prostatectomy for the treatment of patients with localized prostate cancer.
The Philips UroNav System integrates pre-procedural imaging with real-time ultrasound for enhanced precision in prostate cancer therapies. Advanced annotation workflow and DynaCAD Urology support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results